Urist Marshall

Insider·Royalty Pharma plc·RPRX·Insider since 2025·Form 4 filings: 13
Trades YTD
6
Trades (12m)
13
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

13 transactions
30 Jan 2026
SOLD
$RPRX
20,000
$41.09
S
23 Jan 2026
SOLD
$RPRX
20,000
$40.26
S
23 Jan 2026
SOLD
$RPRX
20,000
$40.26
S
16 Jan 2026
SOLD
$RPRX
20,000
$39.52
S
09 Jan 2026
SOLD
$RPRX
20,000
$40.78
S
02 Jan 2026
SOLD
$RPRX
20,000
$38.48
S
26 Dec 2025
SOLD
$RPRX
20,000
$39.32
S
19 Dec 2025
SOLD
$RPRX
20,000
$38.38
S
16 Dec 2025
SOLD
$RPRX
20,000
$38.32
S
05 Dec 2025
SOLD
$RPRX
18,242
$39.15
S
05 Dec 2025
SOLD
$RPRX
23,334
$39.15
S
01 Dec 2025
SOLD
$RPRX
18,242
$39.90
S
01 Dec 2025
SOLD
$RPRX
23,333
$39.93
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Royalty Pharma plc

last 30 days

No active insider cluster at Royalty Pharma plc in the last 30 days. Marshall's recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event Marshall is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 10:39 UTC.